RXO (NYSE:RXO – Free Report) had its target price trimmed by Susquehanna from $20.00 to $16.00 in a research note released on Thursday morning, Benzinga reports. The brokerage currently has a negative rating on the stock.
Other equities analysts also recently issued reports about the company. Oppenheimer restated an outperform rating and set a $31.00 price objective on shares of RXO in a research report on Tuesday, September 17th. Benchmark reissued a hold rating on shares of RXO in a research note on Tuesday, August 13th. JPMorgan Chase & Co. raised their price objective on RXO from $25.00 to $26.00 and gave the company an underweight rating in a research note on Thursday, August 8th. Jefferies Financial Group cut their target price on RXO from $33.00 to $31.00 and set a buy rating on the stock in a research report on Tuesday, August 13th. Finally, UBS Group lifted their target price on RXO from $22.00 to $31.00 and gave the company a neutral rating in a research report on Thursday, August 8th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of Hold and a consensus target price of $25.67.
Read Our Latest Stock Report on RXO
RXO Trading Up 1.0 %
RXO (NYSE:RXO – Get Free Report) last released its earnings results on Wednesday, August 7th. The company reported $0.03 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.03. The company had revenue of $930.00 million for the quarter, compared to analyst estimates of $934.14 million. RXO had a positive return on equity of 2.22% and a negative net margin of 0.55%. RXO’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.08 EPS. Equities research analysts predict that RXO will post 0.14 earnings per share for the current fiscal year.
Hedge Funds Weigh In On RXO
A number of institutional investors and hedge funds have recently modified their holdings of RXO. MFN Partners Management LP raised its holdings in RXO by 11.0% during the second quarter. MFN Partners Management LP now owns 17,310,856 shares of the company’s stock valued at $452,679,000 after acquiring an additional 1,722,301 shares during the period. Vanguard Group Inc. increased its position in RXO by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 13,294,483 shares of the company’s stock valued at $290,750,000 after purchasing an additional 45,977 shares during the period. Swedbank AB acquired a new stake in RXO in the 1st quarter worth approximately $76,982,000. Douglas Lane & Associates LLC lifted its stake in RXO by 2.0% during the 2nd quarter. Douglas Lane & Associates LLC now owns 2,698,525 shares of the company’s stock valued at $70,566,000 after acquiring an additional 52,378 shares during the period. Finally, Dimensional Fund Advisors LP increased its holdings in shares of RXO by 9.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,032,929 shares of the company’s stock valued at $53,153,000 after purchasing an additional 176,041 shares in the last quarter. 92.73% of the stock is currently owned by hedge funds and other institutional investors.
RXO Company Profile
RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Featured Stories
- Five stocks we like better than RXO
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- CarMax’s Impressive Rally: What Investors Should Watch Next
- How to Use the MarketBeat Stock Screener
- MarketBeat Week in Review – 9/23 – 9/27
- Stock Market Upgrades: What Are They?
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.